Ajanta Pharma Shares
- All
- News
-
Ajanta Pharma Gains 4% After Board Approves Rs 286-Crore Share Buyback Plan
Ajanta Pharma Share Price: On Tuesday, shares of Ajanta Pharma settled 3.83 per cent higher at Rs 2,263.90 apiece on the BSE.
-
Stocks To Watch: Coal India, Dr Reddy's Labs, Auto Shares In Focus Today
List of Stocks in Focus Today: Auto companies, including Tata Motors, Hero MotoCorp and Eicher Motors, are set to hog the limelight on the bourses after reporting stellar sales performance for the month of November
-
Ajanta Pharma Launches Pain Relief Tablets In US
Shares of Ajanta Pharma were trading 0.35 per cent higher at Rs 1,197.10 on the BSE.
-
Ajanta Pharma Denies Alert From USFDA, Shares Fall
There were media reports saying the company has got import alert from USFDA for its Paithan unit at Aurangabad for which BSE had sought for a clarification from Ajanta Pharma.
-
Ajanta Pharma Gets USFDA Nod For Generic Acid Reflux Drug
Ajanta Pharma has received nod from the US health regulator for generic Omeprazole and sodium bicarbonate powder for oral suspension used for treatment of stomach and esophagus problems such as ulcers and acid reflux.
-
Ajanta Pharma Posts 39% Rise In Q1 Profit
Drug firm Ajanta Pharma has reported a 38.99 per cent rise in consolidated net profit at Rs 119.55 crore for the quarter ended June 30, 2016, mainly on robust sales.
-
Ajanta Pharma Launches Acid Reflux Drug In US
Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules, used in the treatment of acid reflux and ulcers, in the American market after receiving final approval from the US Food and Drug Administration (FDA).
-
Ajanta Pharma Launches Anti-Dementia Drug In US
In a BSE filing, the company announced "the launch of Memantine Hydrochloride tablets in the US market through its wholly-owned subsidiary Ajanta Pharma USA Inc".
-
Ajanta Pharma touches 52-week high after Q4 results
Shares of Ajanta Pharma touched their 52-week high after the company's net profit rose by 35.10 per cent for Q4
-
M&M proposes to set up Rs 3,000 cr plant in Uttarakhand
Shares of Ajanta Pharma touched their 52-week high after the company's net profit rose by 35.10 per cent for Q4
-
Ajanta Pharma - Change in Registrar & Share Transfer Agent
Ajanta Pharma Limited has informed the Exchange that the details of the company's Registrar & Share Transfer Agents are as under: M/s. Link lntime India Private Limited (formerly M/s. Intime Spectrum Private Limited) C-13, Pannalal Silk Mill Compound, L.B.S. Marg, Bhandup (West), Mumbai - 400078.
-
Ajanta Pharma Gains 4% After Board Approves Rs 286-Crore Share Buyback Plan
Ajanta Pharma Share Price: On Tuesday, shares of Ajanta Pharma settled 3.83 per cent higher at Rs 2,263.90 apiece on the BSE.
-
Stocks To Watch: Coal India, Dr Reddy's Labs, Auto Shares In Focus Today
List of Stocks in Focus Today: Auto companies, including Tata Motors, Hero MotoCorp and Eicher Motors, are set to hog the limelight on the bourses after reporting stellar sales performance for the month of November
-
Ajanta Pharma Launches Pain Relief Tablets In US
Shares of Ajanta Pharma were trading 0.35 per cent higher at Rs 1,197.10 on the BSE.
-
Ajanta Pharma Denies Alert From USFDA, Shares Fall
There were media reports saying the company has got import alert from USFDA for its Paithan unit at Aurangabad for which BSE had sought for a clarification from Ajanta Pharma.
-
Ajanta Pharma Gets USFDA Nod For Generic Acid Reflux Drug
Ajanta Pharma has received nod from the US health regulator for generic Omeprazole and sodium bicarbonate powder for oral suspension used for treatment of stomach and esophagus problems such as ulcers and acid reflux.
-
Ajanta Pharma Posts 39% Rise In Q1 Profit
Drug firm Ajanta Pharma has reported a 38.99 per cent rise in consolidated net profit at Rs 119.55 crore for the quarter ended June 30, 2016, mainly on robust sales.
-
Ajanta Pharma Launches Acid Reflux Drug In US
Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules, used in the treatment of acid reflux and ulcers, in the American market after receiving final approval from the US Food and Drug Administration (FDA).
-
Ajanta Pharma Launches Anti-Dementia Drug In US
In a BSE filing, the company announced "the launch of Memantine Hydrochloride tablets in the US market through its wholly-owned subsidiary Ajanta Pharma USA Inc".
-
Ajanta Pharma touches 52-week high after Q4 results
Shares of Ajanta Pharma touched their 52-week high after the company's net profit rose by 35.10 per cent for Q4
-
M&M proposes to set up Rs 3,000 cr plant in Uttarakhand
Shares of Ajanta Pharma touched their 52-week high after the company's net profit rose by 35.10 per cent for Q4
-
Ajanta Pharma - Change in Registrar & Share Transfer Agent
Ajanta Pharma Limited has informed the Exchange that the details of the company's Registrar & Share Transfer Agents are as under: M/s. Link lntime India Private Limited (formerly M/s. Intime Spectrum Private Limited) C-13, Pannalal Silk Mill Compound, L.B.S. Marg, Bhandup (West), Mumbai - 400078.
